BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30926791)

  • 1. PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice.
    Weber J; de la Rosa J; Grove CS; Schick M; Rad L; Baranov O; Strong A; Pfaus A; Friedrich MJ; Engleitner T; Lersch R; Öllinger R; Grau M; Menendez IG; Martella M; Kohlhofer U; Banerjee R; Turchaninova MA; Scherger A; Hoffman GJ; Hess J; Kuhn LB; Ammon T; Kim J; Schneider G; Unger K; Zimber-Strobl U; Heikenwälder M; Schmidt-Supprian M; Yang F; Saur D; Liu P; Steiger K; Chudakov DM; Lenz G; Quintanilla-Martinez L; Keller U; Vassiliou GS; Cadiñanos J; Bradley A; Rad R
    Nat Commun; 2019 Mar; 10(1):1415. PubMed ID: 30926791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PiggyBac Transposon-Based Insertional Mutagenesis in Mice.
    Friedrich MJ; Bronner IF; Liu P; Bradley A; Rad R
    Methods Mol Biol; 2019; 1907():171-183. PubMed ID: 30543000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. piggyBac mediates efficient in vivo CRISPR library screening for tumorigenesis in mice.
    Xu C; Qi X; Du X; Zou H; Gao F; Feng T; Lu H; Li S; An X; Zhang L; Wu Y; Liu Y; Li N; Capecchi MR; Wu S
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):722-727. PubMed ID: 28062688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in functional genetic screening with transposons and CRISPR/Cas9 to illuminate cancer biology.
    O'Donnell KA
    Curr Opin Genet Dev; 2018 Apr; 49():85-94. PubMed ID: 29587177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma.
    Ni TK; Landrette SF; Bjornson RD; Bosenberg MW; Xu T
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):E3640-9. PubMed ID: 24003131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer.
    Rad R; Rad L; Wang W; Strong A; Ponstingl H; Bronner IF; Mayho M; Steiger K; Weber J; Hieber M; Veltkamp C; Eser S; Geumann U; Öllinger R; Zukowska M; Barenboim M; Maresch R; Cadiñanos J; Friedrich M; Varela I; Constantino-Casas F; Sarver A; Ten Hoeve J; Prosser H; Seidler B; Bauer J; Heikenwälder M; Metzakopian E; Krug A; Ehmer U; Schneider G; Knösel T; Rümmele P; Aust D; Grützmann R; Pilarsky C; Ning Z; Wessels L; Schmid RM; Quail MA; Vassiliou G; Esposito I; Liu P; Saur D; Bradley A
    Nat Genet; 2015 Jan; 47(1):47-56. PubMed ID: 25485836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice.
    Dupuy AJ; Rogers LM; Kim J; Nannapaneni K; Starr TK; Liu P; Largaespada DA; Scheetz TE; Jenkins NA; Copeland NG
    Cancer Res; 2009 Oct; 69(20):8150-6. PubMed ID: 19808965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.
    Mestre-Escorihuela C; Rubio-Moscardo F; Richter JA; Siebert R; Climent J; Fresquet V; Beltran E; Agirre X; Marugan I; Marín M; Rosenwald A; Sugimoto KJ; Wheat LM; Karran EL; García JF; Sanchez L; Prosper F; Staudt LM; Pinkel D; Dyer MJ; Martinez-Climent JA
    Blood; 2007 Jan; 109(1):271-80. PubMed ID: 16960149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Sleeping Beauty transposon insertions in solid tumors using linker-mediated PCR.
    Janik CL; Starr TK
    J Vis Exp; 2013 Feb; (72):e50156. PubMed ID: 23407503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
    Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
    Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forward and Reverse Genetics of B Cell Malignancies: From Insertional Mutagenesis to CRISPR-Cas.
    Dawes JC; Uren AG
    Front Immunol; 2021; 12():670280. PubMed ID: 34484175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf
    Chapeau EA; Gembarska A; Durand EY; Mandon E; Estadieu C; Romanet V; Wiesmann M; Tiedt R; Lehar J; de Weck A; Rad R; Barys L; Jeay S; Ferretti S; Kauffmann A; Sutter E; Grevot A; Moulin P; Murakami M; Sellers WR; Hofmann F; Jensen MR
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3151-3156. PubMed ID: 28265066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system.
    LaFleur MW; Nguyen TH; Coxe MA; Yates KB; Trombley JD; Weiss SA; Brown FD; Gillis JE; Coxe DJ; Doench JG; Haining WN; Sharpe AH
    Nat Commun; 2019 Apr; 10(1):1668. PubMed ID: 30971695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model.
    Bric A; Miething C; Bialucha CU; Scuoppo C; Zender L; Krasnitz A; Xuan Z; Zuber J; Wigler M; Hicks J; McCombie RW; Hemann MT; Hannon GJ; Powers S; Lowe SW
    Cancer Cell; 2009 Oct; 16(4):324-35. PubMed ID: 19800577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo functional screening for systems-level integrative cancer genomics.
    Weber J; Braun CJ; Saur D; Rad R
    Nat Rev Cancer; 2020 Oct; 20(10):573-593. PubMed ID: 32636489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas.
    Noorani I; de la Rosa J; Choi YH; Strong A; Ponstingl H; Vijayabaskar MS; Lee J; Lee E; Richard-Londt A; Friedrich M; Furlanetto F; Fuente R; Banerjee R; Yang F; Law F; Watts C; Rad R; Vassiliou G; Kim JK; Santarius T; Brandner S; Bradley A
    Genome Biol; 2020 Jul; 21(1):181. PubMed ID: 32727536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genes associated with cortical malformation using a transposon-mediated somatic mutagenesis screen in mice.
    Lu IL; Chen C; Tung CY; Chen HH; Pan JP; Chang CH; Cheng JS; Chen YA; Wang CH; Huang CW; Kang YN; Chang HY; Li LL; Chang KP; Shih YH; Lin CH; Kwan SY; Tsai JW
    Nat Commun; 2018 Jun; 9(1):2498. PubMed ID: 29950674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
    Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
    BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.